UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model

Cancer biology & therapy, 2015-10, Vol.16 (11), p.1682-1688

2015

Volltextzugriff (PDF)

BRCA1 Interacts with Components of the Histone Deacetylase Complex

Proceedings of the National Academy of Sciences - PNAS, 1999-04, Vol.96 (9), p.4983-4988

1999

Volltextzugriff (PDF)

BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions

Molecular cancer therapeutics, 2006-06, Vol.5 (6), p.1396-1404

2006

Volltextzugriff (PDF)

Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1

Journal of endocrinology, 2006-12, Vol.191 (3), p.605-612

2006

Volltextzugriff (PDF)

Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent

Molecular carcinogenesis, 2010-06, Vol.49 (6), p.545-555

2010

Volltextzugriff (PDF)

Colorectal cancer care in the age of coronavirus: strategies to reduce risk and maintain benefit

Colorectal cancer, 2020-03, Vol.9 (1)

2020

Volltextzugriff (PDF)

BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrest

The international journal of biochemistry & cell biology, 2012-11, Vol.44 (11), p.1761-1769

2012

Volltextzugriff (PDF)

BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage

Nature genetics, 2002-03, Vol.30 (3), p.285-289

2002

Volltextzugriff (PDF)

Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells

Oncotarget, 2014-03, Vol.5 (6), p.1683-1698

2014

Volltextzugriff (PDF)

Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair

Oncotarget, 2016-03, Vol.7 (12), p.13984-14001

2016

Volltextzugriff (PDF)

Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations

Cancer letters, 2007-11, Vol.257 (2), p.236-243

2007

Volltextzugriff (PDF)

Estrogen receptor regulates insulin-like growth factor-1 receptor gene expression in breast tumor cells : involvement of transcription factor Sp1

Journal of endocrinology, 2006-12, Vol.191 (3), p.605-612

2006

Volltextzugriff (PDF)

Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and growth inhibition of breast cancer cells and cancer stem-like cells

Oncotarget, 2014-12, Vol.5 (23), p.11827-11846

2014

Volltextzugriff (PDF)

MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish–Ashkenazi descent

Breast cancer research and treatment, 2008-10, Vol.111 (3), p.497-504

2008

Volltextzugriff (PDF)

Evaluation of EGFR, KRAS, and TP53 mutations as predictive of disease recurrence in resected early non-small cell lung carcinomas (NSCLCs)

Memo - Magazine of European medical oncology, 2014-02, Vol.7 (1), p.10-15

2014

Volltextzugriff (PDF)

Abstract 3347: Young onset colorectal cancer patients are diagnosed with advanced disease after multiple misdiagnoses

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3347-3347

2019

Volltextzugriff (PDF)

Abstract 342: Strigolactone analogues show potential as new combination therapy agents against pancreatic cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.342-342

2018

Volltextzugriff (PDF)

Abstract 5575: Strigolactones: a novel class of plant hormones inhibit cancer cell and cancer stem-like cell growth and survival

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5575-5575

2013

Volltextzugriff (PDF)

BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation

Oncogene, 2013-10, Vol.32 (42), p.5005-5016

2013

Volltextzugriff (PDF)

Abstract 5122: Utilizing zebrafish to study the effect strigolactone on breast cancer cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5122-5122

2017

Volltextzugriff (PDF)

Abstract 79: The role of BRCA1 and SUMO in ubiquitination of cyclinb1

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.79-79

2012

Volltextzugriff (PDF)

Abstract 1716: BRCA1 expression modulates apoptosis and survival in response to retinoic acid in breast cancer cells

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1716-1716

2010

Volltextzugriff (PDF)

Estrogen suppression of EGFR expression in breast cancer cells: A possible mechanism to modulate growth

Journal of cellular biochemistry, 2001, Vol.81 (S36), p.232-246

2001

Volltextzugriff (PDF)

Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogramed primary prostate cancer cells

Oncotarget, 2014-04, Vol.5 (6), p.1683-1698

2014

Volltextzugriff (PDF)

Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells

Endocrinology (Philadelphia), 1996-07, Vol.137 (7), p.2739-2747

1996

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(77)
Dissertationen
(1)

Sprache

Englisch
(78)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model

BRCA1 Interacts with Components of the Histone Deacetylase Complex

BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions

Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1

Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent

Colorectal cancer care in the age of coronavirus: strategies to reduce risk and maintain benefit

BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrest

BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage

Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells

Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair

Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations

Estrogen receptor regulates insulin-like growth factor-1 receptor gene expression in breast tumor cells : involvement of transcription factor Sp1

Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and growth inhibition of breast cancer cells and cancer stem-like cells

MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish–Ashkenazi descent

Evaluation of EGFR, KRAS, and TP53 mutations as predictive of disease recurrence in resected early non-small cell lung carcinomas (NSCLCs)

Abstract 3347: Young onset colorectal cancer patients are diagnosed with advanced disease after multiple misdiagnoses

Abstract 342: Strigolactone analogues show potential as new combination therapy agents against pancreatic cancer

Abstract 5575: Strigolactones: a novel class of plant hormones inhibit cancer cell and cancer stem-like cell growth and survival

BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation

Abstract 5122: Utilizing zebrafish to study the effect strigolactone on breast cancer cells

Abstract 79: The role of BRCA1 and SUMO in ubiquitination of cyclinb1

Abstract 1716: BRCA1 expression modulates apoptosis and survival in response to retinoic acid in breast cancer cells

Estrogen suppression of EGFR expression in breast cancer cells: A possible mechanism to modulate growth

Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogramed primary prostate cancer cells

Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells

Suchergebnisse filtern